In this research, we investigated the underlying molecular mechanism of ADGRD1 across cancers; downregulation of ADGRD1 expression in NSCLC was significantly correlated with prognosis, TMB, MSI, tumor microenvironment, and immune infiltrating cells. Here, ADGRD1 is linked to cancer.